Beta Bionics granted FDA approval for bionic pancreas
The iLet Bionic Pancreas uses an algorithm alongside a pump and a glucose monitor to make insulin dosing automatic.
by christian bundgaard, translated by daniel pedersen
Late Friday, the US Food and Drug Authority (FDA) gave its nod to Beta Bionics’s newest devices for people as young as six years old with type 1 diabetes.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Bionic pancreas system nears commercial launch
For subscribers
Eli Lilly’s CEO promises not to raise insulin prices
For subscribers
Novo submits new weekly insulin for marketing clearance
For subscribers
